Adaptin Bio raises $1M in private placement of 200,000 shares at $5.00 each

ADAPTIN BIO, INC.

Gross proceeds of $1.0 million from sale of 200,000 shares at $5.00 per share in a private placement.
Placement agent receives 10% cash commission and warrants for 10% of shares sold, exercisable at $5.00 for 5 years.
Company will file resale registration statement; 12% per annum penalty for registration delays.
Holders get piggyback registration rights subject to underwriter cut-back on a pro rata basis.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

ADAPTIN BIO, INC. issued 200,000 shares of common stock to certain investors for $5.00 per Share for gross proceeds of $1.0 million.

Security: common stock
Shares: 200,000 shares
Purchaser: certain investors
Consideration: $5.00 per Share for gross proceeds of $1.0 million

Exact text from the filing

On December 22, 2025, Adaptin Bio, Inc. (the “Company”) entered into a subscription agreement (the “Subscription Agreement”) with certain investors and sold 200,000 shares (the “Shares”) of the Company’s common stock (the “Common Stock”) at $5.00 per Share for gross proceeds of $1.0 million in a closing of a private placement offering (the “Offering”).

View on SEC.gov

Browse all equity issuances →

ADAPTIN BIO, INC. filing history →

Source: SEC EDGAR

accession 0001213900-25-125451

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.